Anika Therapeutics Inc (NAS:ANIK)
$ 17.35 -0.2 (-1.14%) Market Cap: 254.10 Mil Enterprise Value: 219.27 Mil PE Ratio: 0 PB Ratio: 1.42 GF Score: 70/100

Anika Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 16, 2020 / 03:30PM GMT
Release Date Price: $34.8 (+2.41%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Anika Therapeutics 2020 Annual Meeting of Stockholders. I would now like to hand the conference over to one of your speakers today, Ms. Cheryl Blanchard, President and CEO. Ma'am, please go ahead.

Cheryl R. Blanchard
Anika Therapeutics, Inc. - President, CEO & Director

Thank you, Michelle, and good morning, everyone. I'm Cheryl Blanchard, President and Chief Executive Officer of Anika Therapeutics.

Before we move on to the business of this meeting, I would like to thank each of you for joining us virtually today. It is my privilege to welcome you to the Anika Therapeutics 2020 Annual Meeting of Stockholders. We're excited to be hosting our first virtual meeting, which allows us to be more inclusive and reach a greater number of stockholders.

We have stockholders participating via the web portal and the 1 (800) number that we have provided and have provided the broader public with listen-only access.

Today, I will preside as Chair of this meeting; and David

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot